About Carol Rae
Carol Rae is a director at Immutrix Therapeutics.
Carol Rae first appears on SEC filings in 2015.
Experience
This experience comes from SEC filings. The years are when the filings name Carol Rae in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Carol Rae works with at each company, as listed on that company's latest Form D.
Immutrix Therapeutics, Inc. · Form D, Sep 22, 2025
DS
Dan Smith
Chief Operating Officer
BH
Brad Hennrich
Director
RO
Rich Otto
Director
LB
Lonnie Bookbinder
Director
RS
Ronald Shape
President, CEO and CFO, director
SU
Stephanie D'Urso
Director
RM
Russell McCulloh
Director